Date published: 2025-11-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

BMS-740808 (CAS 280118-23-2)

0.0(0)
Write a reviewAsk a question

Application:
BMS-740808 is a highly potent, selective inhibitor of Factor X
CAS Number:
280118-23-2
Molecular Weight:
588.58
Molecular Formula:
C31H27F3N6O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

BMS-740808 is a highly potent, selective inhibitor of Factor X, with Ki of 0.03 nM. BMS-740808 is highly potent with a rapid onset of inhibition (2.7 × 107 M-1 s-1), selective (>1000-fold over other proteases), efficacious in the AVShunt thrombosis model. BMS-740808 is synthesized by modification of employing bicyclic pyrazolo-pyridinone scaffold to Razaxaban, a pyrazole based Factor X inhibitor. Especially for BMS-740808, the introduction of a 3(R)-hydroxyl moiety on the pyrrolidine ring results in a significant enhancement in potency. BMS-740808 also shows the high affinity for thrombin.


BMS-740808 (CAS 280118-23-2) References

  1. 1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa.  |  Pinto, DJ., et al. 2006. Bioorg Med Chem Lett. 16: 4141-7. PMID: 16730984
  2. Discovery of potent, efficacious, and orally bioavailable inhibitors of blood coagulation factor Xa with neutral P1 moieties.  |  Pinto, DJ., et al. 2006. Bioorg Med Chem Lett. 16: 5584-9. PMID: 16963264
  3. Structure-activity relationship and pharmacokinetic profile of 5-ketopyrazole factor Xa inhibitors.  |  Varnes, JG., et al. 2008. Bioorg Med Chem Lett. 18: 749-54. PMID: 18054227
  4. Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor.  |  Wong, PC., et al. 2011. J Thromb Thrombolysis. 31: 478-92. PMID: 21318583
  5. Advances in Inhibitors of FXa.  |  Guo, L. and Ma, S. 2015. Curr Drug Targets. 16: 1207-32. PMID: 25981610
  6. Contemporary medicinal-chemistry strategies for discovery of blood coagulation factor Xa inhibitors.  |  Hao, X., et al. 2019. Expert Opin Drug Discov. 14: 915-931. PMID: 31172842

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

BMS-740808, 10 mg

sc-364445
10 mg
$480.00

BMS-740808, 50 mg

sc-364445A
50 mg
$1455.00